Bemtgen, Xavier http://orcid.org/0000-0001-7309-7729
Kaier, Klaus
Rilinger, Jonathan
Rottmann, Felix
Supady, Alexander
von zur Mühlen, Constantin
Westermann, Dirk
Wengenmayer, Tobias
Staudacher, Dawid L.
Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Received: 25 July 2022
Accepted: 7 December 2022
First Online: 24 December 2022
Declarations
:
: DLS reports lecture fees from Abiomed, OrionPharma, GetingeGroup, Medtronic, AstraZeneca, and Dahlhausen all of which are outside the submitted work. XB reports lecture fees from Amomed, outside of the submitted work. AS reports research grants, lecture fees and travel support from CytoSorbents and lecture fees from Abiomed, both outside the submitted work. The other authors declare that they have no competing interests.
: As this study did not involve direct access to individual patient data and patient anonymity was guaranteed by DESTATIS, approval by an ethics committee or informed consent was not required in accordance with German law.
: Not applicable.